One Episode of Self-Resolving Plasmodium yoelii Infection Transiently Exacerbates Chronic Mycobacterium tuberculosis Infection.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26913029)

Published in Front Microbiol on February 15, 2016

Authors

Jannike Blank1, Lars Eggers1, Jochen Behrends2, Thomas Jacobs3, Bianca E Schneider1

Author Affiliations

1: Division of Coinfection, Priority Research Area Infections, Research Center Borstel Borstel, Germany.
2: Fluorescence Cytometry Core Facility, Research Center Borstel Borstel, Germany.
3: Department of Immunology, Bernhard Nocht Institute for Tropical Medicine Hamburg, Germany.

Articles cited by this

Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet (2012) 17.62

Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med (1992) 10.08

Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci U S A (1997) 7.90

Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov (2007) 6.33

IL-10: the master regulator of immunity to infection. J Immunol (2008) 6.11

Immunity to malaria: more questions than answers. Nat Immunol (2008) 5.71

Marked increase in child survival after four years of intensive malaria control. Am J Trop Med Hyg (2009) 5.50

Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun (1995) 4.28

IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J Immunol (1992) 3.98

TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol (2002) 3.96

The immune response in tuberculosis. Annu Rev Immunol (2013) 3.91

Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J Immunol (2007) 3.73

Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J Exp Med (2007) 3.67

Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc Natl Acad Sci U S A (2007) 3.41

IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest (2000) 3.19

Immunosuppression in children with malaria. Lancet (1972) 3.11

Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J Immunol (2008) 3.04

Protection of mice against Babesia and Plasmodium with BCG. Nature (1976) 3.01

Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol (2014) 2.92

The non-specific effects of vaccines. Arch Dis Child (2010) 2.42

Impairment of the immune response to vaccination after acute malaria. Lancet (1978) 2.39

Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1β. Nat Immunol (2012) 2.34

Plasmodium falciparum malaria and Salmonella infections in Gambian children. J Infect Dis (1987) 2.23

Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection. J Exp Med (2011) 2.22

Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J Clin Invest (2010) 2.22

T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol (1997) 2.18

Interferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis. Immunity (2009) 2.05

IL-10 from CD4CD25Foxp3CD127 adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection. PLoS Pathog (2008) 2.01

Innate immunity in tuberculosis: myths and truth. Microbes Infect (2008) 2.00

Increased antimycobacterial immunity in interleukin-10-deficient mice. Infect Immun (1999) 1.95

Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung. Infect Immun (2000) 1.92

Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clin Infect Dis (2005) 1.88

Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung. Eur J Immunol (2010) 1.84

Fate of Mycobacterium tuberculosis within murine dendritic cells. Infect Immun (2001) 1.79

Malaria blood stage suppression of liver stage immunity by dendritic cells. J Exp Med (2003) 1.78

NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. J Immunol (2006) 1.76

T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria. Nature (1985) 1.69

Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells. J Exp Med (2001) 1.62

IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection. J Immunol (2011) 1.56

Short report: modulation of Mycobacterium tuberculosis infection by Plasmodium in the murine model. Am J Trop Med Hyg (2004) 1.54

NK cells respond to pulmonary infection with Mycobacterium tuberculosis, but play a minimal role in protection. J Immunol (2003) 1.49

Malarial immunodepression in vitro: adherent spleen cells are functionally defective as accessory cells in the response to horse erythrocytes. Eur J Immunol (1976) 1.47

TNFR1-induced NF-kappaB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells. Cell Signal (2007) 1.47

Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity. J Immunol (2009) 1.47

Interferon gamma activated macrophages kill mycobacteria by nitric oxide induced apoptosis. PLoS One (2011) 1.46

Malaria's indirect contribution to all-cause mortality in the Andaman Islands during the colonial era. Lancet Infect Dis (2008) 1.40

BCG vaccination scar associated with better childhood survival in Guinea-Bissau. Int J Epidemiol (2005) 1.38

Dendritic cells, pro-inflammatory responses, and antigen presentation in a rodent malaria infection. Immunol Rev (2004) 1.36

The development and function of lung-resident macrophages and dendritic cells. Nat Immunol (2015) 1.31

Cutting edge: conventional dendritic cells are the critical APC required for the induction of experimental cerebral malaria. J Immunol (2007) 1.31

Salmonella efficiently enter and survive within cultured CD11c+ dendritic cells initiating cytokine expression. Eur J Immunol (1999) 1.31

The nonspecific effects of vaccines and the expanded program on immunization. J Infect Dis (2011) 1.26

Impaired cell-mediated immunity in Plasmodium falciparum-infected patients with high-parasitemia and cerebral malaria. Clin Immunol Immunopathol (1983) 1.26

Bacillus Calmette-Guérin vaccination and infant mortality. Expert Rev Vaccines (2006) 1.21

Classical CD11c+ dendritic cells, not plasmacytoid dendritic cells, induce T cell responses to Plasmodium chabaudi malaria. Int J Parasitol (2009) 1.16

Loss of cellular immune reactivity during acute Plasmodium falciparum malaria. FEMS Microbiol Immunol (1991) 1.15

Immunopathology and dexamethasone therapy in a new model for malaria-associated acute respiratory distress syndrome. Am J Respir Crit Care Med (2010) 1.14

Suppressive activity of splenic adherent cells from Plasmodium chabaudi-infected mice. J Immunol (1980) 1.13

Plasmodium strain determines dendritic cell function essential for survival from malaria. PLoS Pathog (2007) 1.12

Depression of immune response to Moloney leukaemia virus by malarial infection. Nature (1973) 1.10

Host defenses in murine malaria: nonspecific resistance to Plasmodium berghei generated in response to Mycobacterium bovis infection or Corynebacterium parvum stimulation. Infect Immun (1981) 1.07

Hemozoin induces lung inflammation and correlates with malaria-associated acute respiratory distress syndrome. Am J Respir Cell Mol Biol (2013) 1.06

Malaria pigment paralyzes dendritic cells. J Biol (2006) 1.05

IFN-gamma inhibits activation-induced expression of E- and P-selectin on endothelial cells. J Immunol (1998) 1.01

Herpes zoster in children following malaria. J Trop Med Hyg (1985) 1.00

Malaria exacerbates experimental mycobacterial infection in vitro and in vivo. Microbes Infect (2010) 0.99

Splenic and hepatic hemozoin in mice after malaria parasite clearance. J Parasitol (1999) 0.98

Increased dendritic cell numbers impair protective immunity to intracellular bacteria despite augmenting antigen-specific CD8+ T lymphocyte responses. J Immunol (2004) 0.97

Mycobacterium bovis bacillus calmette-guérin induces protective immunity against infection by Plasmodium yoelii at blood-stage depending on shifting immunity toward Th1 type and inducing protective IgG2a after the parasite infection. Vaccine (2000) 0.94

Use of a quantitative TaqMan-PCR for the fast quantification of mycobacteria in broth culture, eukaryotic cell culture and tissue. J Vet Med B Infect Dis Vet Public Health (2003) 0.93

Combination of host susceptibility and virulence of Mycobacterium tuberculosis determines dual role of nitric oxide in the protection and control of inflammation. J Infect Dis (2009) 0.93

Beneficial non-targeted effects of BCG--ethical implications for the coming introduction of new TB vaccines. Tuberculosis (Edinb) (2006) 0.92

Mycobacterium-induced potentiation of type 1 immune responses and protection against malaria are host specific. Infect Immun (2005) 0.90

The host response in malaria and depression of defence against tuberculosis. Ann Trop Med Parasitol (1999) 0.90

Malaria prevention reduces in-hospital mortality among severely ill tuberculosis patients: a three-step intervention in Bissau, Guinea-Bissau. BMC Infect Dis (2011) 0.89

Rodent malaria: BCG-induced protection and immunosuppression. J Immunol (1978) 0.89

A Plasmodium yoelii soluble factor inhibits the phenotypic maturation of dendritic cells. Malar J (2008) 0.88

Extramedullary myelopoiesis in malaria depends on mobilization of myeloid-restricted progenitors by IFN-γ induced chemokines. PLoS Pathog (2013) 0.88

Molecular analysis of non-specific protection against murine malaria induced by BCG vaccination. PLoS One (2013) 0.88

Tuberculosis Comorbidity with Communicable and Noncommunicable Diseases. Cold Spring Harb Perspect Med (2015) 0.87

Suppression of vaccine responses by malaria: insignificant or overlooked? Expert Rev Vaccines (2010) 0.86

Natural transmission of Plasmodium berghei exacerbates chronic tuberculosis in an experimental co-infection model. PLoS One (2012) 0.85

Placental malaria is associated with attenuated CD4 T-cell responses to tuberculin PPD 12 months after BCG vaccination. BMC Infect Dis (2012) 0.83

BCG-malaria co-Infection has paradoxical effects on C57BL/6 and A/J mouse strains. Parasite Immunol (2008) 0.80

In Vivo Hemozoin Kinetics after Clearance of Plasmodium berghei Infection in Mice. Malar Res Treat (2012) 0.80

Mycobacterium-Infected Dendritic Cells Disseminate Granulomatous Inflammation. Sci Rep (2015) 0.78

Plasmodium yoelii in mice: antigen reactivity of CD4- and CD8-bearing T cells. Cell Immunol (1993) 0.78

Isolation of mouse lung dendritic cells. J Vis Exp (2011) 0.77